iSpecimen Inc. Payments of Debt Issuance Costs
iSpecimen Inc. (ISPC) reported Payments of Debt Issuance Costs of $140.02 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-11-17
- iSpecimen Inc. payments of debt issuance costs for the quarter ending 2021-12-31 was $7.09K.
- iSpecimen Inc. payments of debt issuance costs for fiscal 2021 was $32.92K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2024-09-30 | $140.02K 10-Q · filed 2025-11-17 | ||
| 2021-12-31 | $7.09K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $32.92K 10-K/A · filed 2023-03-30 | |
| 2021-09-30 | $25.82K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |